Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Oct 29, 2010

Premium

Emerald Biostructures announced this week the formation of its scientific advisory board to which it appointed John Hunt, John McCall, John Mulligan, and Lynn Silver.

Hunt is an associate professor at Columbia University and the co-director of the crystallography group Northeast Structural Genomics. McCall is the president of PharMac and was previously vice president of research at Pfizer and global head of chemistry at Pharmacia and Pharmacia & Upjohn. Mulligan is the founder and former CEO of Blue Heron Biotechnology, which was acquired in August by OriGene. Silver currently works as a consultant in preclinical development and antibacterial discovery for the pharmaceutical industry. Previously, she was a researcher at Merck.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.